Later, other studies have reported the same decreased activity of the NHEJ pathway in BRCA1-deficient HCC1937 [63], and lymphoblastoid cell lines derived from breast cancer patients [64, 65]. The gene discussed is BRCA1; the disease is breast carcinoma.